• 40.1k views

Therapeutic options for MRSA

Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted against resistant strains. In cases of severe infections, such as bloodstream infections or pneumonia, newer agents like ceftaroline and telavancin may be employed. Combination therapy with rifampin or other adjunctive treatments can also enhance effectiveness. Surgical interventions, such as drainage of abscesses or debridement of infected tissue, are often necessary in conjunction with antibiotic therapy to ensure full recovery.

About the Speaker

Dr. Rishabh Kumar Mittal Profile Image

Dr. Rishabh Kumar Mittal

Additional Director & HOD of Critical Care Medicine, Fortis Hospital, Manesar, Gurgaon

Dr Rishabh Kumar Mittal is a well known intensive care physician having more than 12 years of experience in the field of Critical Care Medicine. After completing his post graduation from prestigious S.M.S Medical College and attached group hospitals , Jaipur; he ventured in the field of Critical Care Medicine and completed F.N.B in Critical Care Medicine from Fortis Escorts Heart Institute, New Delhi. He is an astute clinician and academician and is a teacher & guide for DrNB,F.N.B, IDCCM, IFCCM and IDCCN courses in Critical Care Medicine. He has published many articles in indexed journals and has written many chapter in various critical care medicine books. He has delivered many talks in Critical Care and Anaesthesiology National and International conferences. His key areas of interest are Nutrition in Critically ill, Ventilation in ARDS patients , ECMO, Gastro Critical care, Post organ transplant care and antibiotic stewardship in Critical Care. Before joining Max Hospital , Dr Rishabh has served as academic coordinator and In-charge of Gastro Medical & Liver Transplant Intensive care units at Fortis Escorts Hospital, New Delhi.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Rishabh Kumar Mittal's Talks on Assimilate

webinar
Dr. Rishabh Kumar Mittal
  • 26th -Sep -2024, TIME : 2:00PM TO 3:00 PM
  • 0

Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted against resistant strains. In cases of severe infections, such as bloodstream infections or pneumonia, newer agents like ceftaroline and telavancin may be employed. Combination therapy with rifampin or other adjunctive treatments can also enhance effectiveness. Surgical interventions, such as drainage of abscesses or debridement of infected tissue, are often necessary in conjunction with antibiotic therapy to ensure full recovery.

webinar
Dr. Rishabh Kumar Mittal
  • 26th -Sep -2024, TIME : 2:00PM TO 3:00 PM
  • 0

Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted against resistant strains. In cases of severe infections, such as bloodstream infections or pneumonia, newer agents like ceftaroline and telavancin may be employed. Combination therapy with rifampin or other adjunctive treatments can also enhance effectiveness. Surgical interventions, such as drainage of abscesses or debridement of infected tissue, are often necessary in conjunction with antibiotic therapy to ensure full recovery.

webinar
Dr. Rishabh Kumar Mittal
  • 26th -Sep -2024, TIME : 2:00PM TO 3:00 PM
  • 0

Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted against resistant strains. In cases of severe infections, such as bloodstream infections or pneumonia, newer agents like ceftaroline and telavancin may be employed. Combination therapy with rifampin or other adjunctive treatments can also enhance effectiveness. Surgical interventions, such as drainage of abscesses or debridement of infected tissue, are often necessary in conjunction with antibiotic therapy to ensure full recovery.